House approves $3.2 billion FDA budget
The House of Representatives passed a four-bill appropriations minibus for fiscal year 2021 that includes an amendment giving the FDA the authority to recall drugs. The agency’s proposed budget also includes targeted boosts to spending for medical product and food safety activities and influenza vaccine manufacturing technologies.
Other targeted initiatives include cross-departmental initiatives designed to enhance food and medical product safety; additionally, “[T]he bill includes a strong focus on continuing FDA’s efforts to enable faster responses to foodborne illness outbreaks and increase the safety and cybersecurity of medical devices,” according to the House Appropriations Committee’s summary of the minibus.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
